United States

People: GlaxoSmithKline PLC (GLAXF.PK)

GLAXF.PK on OTC Markets Group

29 Jul 2016
Change (% chg)

$-0.10 (-0.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Redfern, David 

Mr. David Redfern is Chief Strategy Officer of GlaxoSmithKline PLC. He is responsible for proactive exploration of new business opportunities, strategic planning and the leadership of the dermatology business. In addition to his current role, he was appointed Chairman of the Board of ViiV Healthcare Ltd. in April 2011. Previously, he was Senior Vice President, Northern Europe with responsibility for managing GSK’s pharmaceutical businesses in that region and prior to that Senior Vice President for Central and Eastern Europe. David joined the company in 1994 and held a series of finance roles before becoming Finance Director of the European business from 1999-2002. David has a Bachelor of Science degree from Bristol University in the UK and is a Chartered Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --